The Journal of
Clinical Psychiatry

Depression (MDD)

The Journal of Clinical Psychiatry

Article February 1, 1997

Antidepressants

Alan Frazer, Ph.D.

J Clin Psychiatry 1997;58(suppl 6):9-25

Article Abstract

This review covers the chemical structures, efficacy, side effects, toxicity, and mechanisms of actionof various classes of antidepressants: tricyclic antidepressants, monoamine oxidase inhibitors,and second generation antidepressants including the serotonin selective reuptake inhibitors, and noveldrugs such as mirtazapine, nefazodone, and venlafaxine.

About the Authors

Alan Frazer, Ph.D.

View full profile

Download Free PDF

This PDF is free for all visitors!

Vol 87 • 2026 • Number 1

Read the Current Issue

ASCP Corner

Rethinking Amisulpride: Could N-Methylation Result in a New and Even Better Antipsychotic?

Original Research

How Many Criteria Should be Required to Define the DSM-5 Mixed Features Specifier in Depressed Patients?

Meta-Analysis

Effectiveness of Peer-Administered Interventions for Perinatal Depression or Anxiety

Original Research

Innovation in Psychiatric Drug Development: A Quantitative Analysis of FDA-Approved Psychiatric Drugs, 2012–2024

Brief Report

Exercise Reduces Dysphoria in Clinical High-Risk for Psychosis: A Randomized Controlled Trial

Clinical and Practical Psychopharmacology

Pregabalin in Pregnancy: Major Congenital Malformations, Other Birth Outcomes, and Neurodevelopmental Outcomes

View current Issue

Article

Brain Zaps

December 20, 2018

Brain zaps are a poorly understood symptom of antidepressant discontinuation, which require further study for both better prevention and treatment. This article describes the characteristics of brain zaps and...

Alexander Papp, Julie A. Onton

Article

ECT in Obsessive-Compulsive-Related Disorders

October 18, 2018

Obsessive-compulsive-related disorders include conditions such as body dysmorphic disorder and skin-picking disorder, as well as tic disorders and self-injurious behaviors. Could electroconvulsive therapy be an effective treatment option? Read...

Leonardo F. Fontenelle, Murat Yücel, Samara dos Santos-Ribeiro, et al

Article

Glabellar Botulinum for Depression

October 4, 2018

Glabellar injection of botulinum toxin A (BTA) provides a novel and interesting strategy to address shortcomings in the treatment of depression. This study examines the primary clinical trials conducted...

Mujeeb U. Shad, Toren P. Stearns, Gabriela C. Guzman

Antidepressants

About the Authors

Read the Current Issue

Rethinking Amisulpride: Could N-Methylation Result in a New and Even Better Antipsychotic?

How Many Criteria Should be Required to Define the DSM-5 Mixed Features Specifier in Depressed Patients?

Effectiveness of Peer-Administered Interventions for Perinatal Depression or Anxiety

Innovation in Psychiatric Drug Development: A Quantitative Analysis of FDA-Approved Psychiatric Drugs, 2012–2024

Exercise Reduces Dysphoria in Clinical High-Risk for Psychosis: A Randomized Controlled Trial

Pregabalin in Pregnancy: Major Congenital Malformations, Other Birth Outcomes, and Neurodevelopmental Outcomes

ELSEWHERE:

FOLLOW US:

Antidepressants

About the Authors

Read the Current Issue

Rethinking Amisulpride: Could N-Methylation Result in a New and Even Better Antipsychotic?

How Many Criteria Should be Required to Define the DSM-5 Mixed Features Specifier in Depressed Patients?

Effectiveness of Peer-Administered Interventions for Perinatal Depression or Anxiety

Innovation in Psychiatric Drug Development: A Quantitative Analysis of FDA-Approved Psychiatric Drugs, 2012–2024

Exercise Reduces Dysphoria in Clinical High-Risk for Psychosis: A Randomized Controlled Trial

Pregabalin in Pregnancy: Major Congenital Malformations, Other Birth Outcomes, and Neurodevelopmental Outcomes

Related Articles

Brain Zaps

ECT in Obsessive-Compulsive-Related Disorders

Glabellar Botulinum for Depression

Consensus Report on XT Use in Practice

Subscribe to readmore articles

Subscribe to read
more articles